IL222773B

Biaryl compounds, pharmaceutical compositions comprising the same, use of such compounds in the manufacture of medicaments and in vitro methods and devices using such compounds

Abstract

Compounds of formula (I) are useful as inhibitors of trypsin like serine protease enzymes such as thrombin, factor VIIa, factor Xa, TF/FVIIa, and trypsin. These compounds could be useful to treat and/or prevent clotting disorders, and as anticoagulating agents.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

29 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
28173501United States of AmericaP
0132582United States of AmericaW

Members29

Family members, oldest first
DocumentOfficeKind
CA2426430A1CanadaA1
WO0234711A1World Intellectual Property Organization (WIPO)A1
AU1339302AAustraliaA
IL155202A0IsraelA0
EP1383731A1European Patent Office (EPO)A1
MXPA03009130AMexicoA
US6699994B1United States of AmericaB1
JP2004523481AJapanA
US2004162281A1United States of AmericaA1
HK1062676A1Hong Kong, ChinaA1
RU2003132706ARussian FederationA
US6936719B2United States of AmericaB2
EP1383731A4European Patent Office (EPO)A4
NZ526003ANew ZealandA
AU2002213393B2AustraliaB2
EP1383731B1European Patent Office (EPO)B1
AT438615TAustriaT
ATE438615T1AustriaT1
DE60139510D1GermanyD1
JP4342178B2JapanB2
PT1383731EPortugalE
DK1383731T3DenmarkT3
ES2332090T3SpainT3
IL222773A0IsraelA0
IL155202AIsraelA
CA2426430CCanadaC
CY1110527T1CyprusT1
IL222773AIsraelA
IL222773BThis recordIsraelB